An Introduction Last Monday, August 26th, the Drug Enforcement Administration (DEA) announced that it had scheduled an administrative hearing for December 2nd to consider differing expert opinions on the Justice Department’s proposal that cannabis be re-classified to that of a Schedule III drug under the Controlled Substances Act (CSA)....
Our Canadian Cannabis LP Portfolio Was DOWN 14% In August
An Introduction On August 26th, the Drug Enforcement Administration (DEA) announced that it had scheduled an administrative hearing for December 2nd to consider differing expert opinions on the Justice Department’s proposal that cannabis be re-classified to that of a Schedule III drug under the Controlled Substances Act (CSA). That...